CESS
Resource Report
Resource Website
|
ECACC Cat# 92110206, RRID:CVCL_0209
|
Homo sapiens (Human)
|
Adult acute myeloid leukemia
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3106068 PMID:6972960 PMID:20164919 PMID:20215515 PMID:27397505 PMID:30894373
|
Transformed cell line
|
Male |
Cess |
ECACC |
92110206 |
BTO:BTO_0004327, CLO:CLO_0002360, EFO:EFO_0002130, MCCL:MCC:0000098, CLDB:cl695, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ATCC:TIB-190, BioSample:SAMN03471942, cancercelllines:CVCL_0209, Cell_Model_Passport:SIDM00917, ChEMBL-Cells:CHEMBL3308863, ChEMBL-Targets:CHEMBL2366361, CLS:300262, Cosmic:683658, Cosmic:910688, Cosmic:2131534, Cosmic:2306201, Cosmic-CLP:910688, DepMap:ACH-002218, ECACC:92110206, EGA:EGAS00001000978, GDSC:910688, GEO:GSM1669671, IARC_TP53:21221, IGRhCellID:CESS, LINCS_LDP:LCL-1050, PharmacoDB:CESS_192_2019, Progenetix:CVCL_0209, PubChem_Cell_line:CVCL_0209, Wikidata:Q54809343 |
|
|
CVCL_0209 |
2026-09-12 05:23:29 |
0 |
CESS
Resource Report
Resource Website
|
RRID:CVCL_0209
|
Homo sapiens (Human)
|
Adult acute myeloid leukemia
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3106068 PMID:6972960 PMID:20164919 PMID:20215515 PMID:27397505 PMID:30894373
|
Transformed cell line
|
Male |
Cess |
|
|
BTO:BTO_0004327, CLO:CLO_0002360, EFO:EFO_0002130, MCCL:MCC:0000098, CLDB:cl695, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ATCC:TIB-190, BioSample:SAMN03471942, cancercelllines:CVCL_0209, Cell_Model_Passport:SIDM00917, ChEMBL-Cells:CHEMBL3308863, ChEMBL-Targets:CHEMBL2366361, CLS:300262, Cosmic:683658, Cosmic:910688, Cosmic:2131534, Cosmic:2306201, Cosmic-CLP:910688, DepMap:ACH-002218, ECACC:92110206, EGA:EGAS00001000978, GDSC:910688, GEO:GSM1669671, IARC_TP53:21221, IGRhCellID:CESS, LINCS_LDP:LCL-1050, PharmacoDB:CESS_192_2019, Progenetix:CVCL_0209, PubChem_Cell_line:CVCL_0209, Wikidata:Q54809343 |
|
|
CVCL_0209 |
2026-09-12 05:23:29 |
0 |
CESS
Resource Report
Resource Website
|
ATCC Cat# TIB-190, RRID:CVCL_0209
|
Homo sapiens (Human)
|
Adult acute myeloid leukemia
|
Population: Caucasian., From: Memorial Sloan Kettering Cancer Center; New York; USA., Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3106068 PMID:6972960 PMID:20164919 PMID:20215515 PMID:27397505 PMID:30894373
|
Transformed cell line
|
Male |
Cess |
ATCC |
TIB-190 |
BTO:BTO_0004327, CLO:CLO_0002360, EFO:EFO_0002130, MCCL:MCC:0000098, CLDB:cl695, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ATCC:TIB-190, BioSample:SAMN03471942, cancercelllines:CVCL_0209, Cell_Model_Passport:SIDM00917, ChEMBL-Cells:CHEMBL3308863, ChEMBL-Targets:CHEMBL2366361, CLS:300262, Cosmic:683658, Cosmic:910688, Cosmic:2131534, Cosmic:2306201, Cosmic-CLP:910688, DepMap:ACH-002218, ECACC:92110206, EGA:EGAS00001000978, GDSC:910688, GEO:GSM1669671, IARC_TP53:21221, IGRhCellID:CESS, LINCS_LDP:LCL-1050, PharmacoDB:CESS_192_2019, Progenetix:CVCL_0209, PubChem_Cell_line:CVCL_0209, Wikidata:Q54809343 |
|
|
CVCL_0209 |
2026-09-12 05:23:29 |
0 |
CGTH-W-1
Resource Report
Resource Website
Contaminated
|
RRID:CVCL_1120
|
Homo sapiens (Human)
|
Thyroid gland squamous cell carcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Contaminated. Shown to be a SW579 derivative (PubMed=25877200; DSMZ). Originally thought to originate from a thyroid gland follicular carcinoma metastasizing to the sternum of a 70 year old Chinese female patient..
|
PMID:8826082 PMID:8888804 PMID:11668190 PMID:20164919 PMID:20215515 PMID:22460905 PMID:23833040 PMID:25877200 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
CGTH-W1, CGTH W-1, CGTHW1 |
|
|
BTO:BTO_0004740, CLO:CLO_0002406, EFO:EFO_0002131, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMN03470999, BioSample:SAMN03473318, BioSample:SAMN10987694, cancercelllines:CVCL_1120, Cell_Model_Passport:SIDM01248, ChEMBL-Cells:CHEMBL3308849, ChEMBL-Targets:CHEMBL2366300, Cosmic:910568, Cosmic:1995365, Cosmic:2054098, Cosmic-CLP:910568, DepMap:ACH-001023, DSMZ:ACC-360, DSMZCellDive:ACC-360, EGA:EGAS00001000978, GDSC:910568, GEO:GSM886926, GEO:GSM887992, GEO:GSM1669673, IARC_TP53:21223, IGRhCellID:CGTHW1, LINCS_LDP:LCL-1691, PharmacoDB:CGTHW1_194_2019, PRIDE:PXD030304, Progenetix:CVCL_1120, PubChem_Cell_line:CVCL_1120, Wikidata:Q54811588 |
cvcl_3603 |
|
CVCL_1120 |
2026-09-12 05:23:37 |
0 |
ChaGo-K-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1121
|
Homo sapiens (Human)
|
Bronchogenic carcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62839 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Male |
CHAGO-K-1, ChaGo K-1, ChaGo-K1, CHAGOK1, ChaGoK1 |
|
|
BTO:BTO_0003108, CLO:CLO_0002413, EFO:EFO_0002155, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-168, BioGRID_ORCS_Cell_line:594, BioSample:SAMN03473197, BioSample:SAMN10987978, cancercelllines:CVCL_1121, Cell_Model_Passport:SIDM00924, ChEMBL-Cells:CHEMBL3308489, ChEMBL-Targets:CHEMBL1075421, Cosmic:687596, Cosmic:1995366, Cosmic-CLP:687596, DepMap:ACH-000867, ECACC:96020948, EGA:EGAS00001000610, EGA:EGAS00001000978, FANTOM5_SSTAR:10710-109H8, GDSC:687596, GEO:GSM784215, GEO:GSM827465, GEO:GSM886927, GEO:GSM887993, GEO:GSM1669674, IARC_TP53:21266, IZSLER:BS TCL 186, LiGeA:CCLE_416, LINCS_LDP:LCL-1579, PharmacoDB:ChaGoK1_196_2019, PRIDE:PXD030304, Progenetix:CVCL_1121, PubChem_Cell_line:CVCL_1121, Wikidata:Q54811725 |
cvcl_dg43 |
|
CVCL_1121 |
2026-09-12 05:23:39 |
2 |
CHL-1
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1122
|
Homo sapiens (Human)
|
Melanoma
|
Population: Caucasian., Part of: ERK genetic alteration cell panel (ATCC TCP-1033)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:20164919 PMID:20215515 PMID:22178978 PMID:22460905 PMID:23637631 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
CHL1 |
|
|
BTO:BTO_0004061, CLO:CLO_0002420, EFO:EFO_0002132, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CRL-3619, ATCC:CRL-9446, BioSample:SAMN03470897, BioSample:SAMN10988230, cancercelllines:CVCL_1122, Cell_Model_Passport:SIDM01228, ChEMBL-Cells:CHEMBL3308722, ChEMBL-Targets:CHEMBL1075422, Cosmic:706115, Cosmic:897494, Cosmic:910853, Cosmic:1459665, Cosmic:1477418, Cosmic:1995367, Cosmic-CLP:910853, DepMap:ACH-001024, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, GDSC:910853, GEO:GSM886928, GEO:GSM887994, GEO:GSM1669675, IARC_TP53:21224, IGRhCellID:CHL1, PharmacoDB:CHL1_197_2019, PRIDE:PXD030304, Progenetix:CVCL_1122, PubChem_Cell_line:CVCL_1122, Wikidata:Q54812129 |
cvcl_2713 |
|
CVCL_1122 |
2026-09-12 05:23:49 |
13 |
CRO-AP5
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-215, RRID:CVCL_1148
|
Homo sapiens (Human)
|
Primary effusion lymphoma
|
Virology: Contains 30 to 60 copies of the human herpesvirus 8 (HHV-8/KSHV) genome per cell., Part of: LL-100 blood cancer cell line panel.
|
PMID:9734661 PMID:9766492 PMID:10784388 PMID:20164919 PMID:20215515 PMID:20454443 PMID:21685375 PMID:31160637
|
Cancer cell line
|
Male |
CRO-AP/5, CROAP5, AP5 |
DSMZ |
ACC-215 |
BTO:BTO_0002726, CLO:CLO_0002619, EFO:EFO_0002146, CLDB:cl420, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioSample:SAMN03473377, cancercelllines:CVCL_1148, Cosmic:906806, DSMZ:ACC-215, DSMZCellDive:ACC-215, GEO:GSM634730, IARC_TP53:21258, IGRhCellID:CROAP5, Progenetix:CVCL_1148, Wikidata:Q54814509 |
|
|
CVCL_1148 |
2026-09-12 05:24:33 |
1 |
CRO-AP5
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1148
|
Homo sapiens (Human)
|
Primary effusion lymphoma
|
Virology: Contains 30 to 60 copies of the human herpesvirus 8 (HHV-8/KSHV) genome per cell., Part of: LL-100 blood cancer cell line panel.
|
PMID:9734661 PMID:9766492 PMID:10784388 PMID:20164919 PMID:20215515 PMID:20454443 PMID:21685375 PMID:31160637
|
Cancer cell line
|
Male |
CRO-AP/5, CROAP5, AP5 |
|
|
BTO:BTO_0002726, CLO:CLO_0002619, EFO:EFO_0002146, CLDB:cl420, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioSample:SAMN03473377, cancercelllines:CVCL_1148, Cosmic:906806, DSMZ:ACC-215, DSMZCellDive:ACC-215, GEO:GSM634730, IARC_TP53:21258, IGRhCellID:CROAP5, Progenetix:CVCL_1148, Wikidata:Q54814509 |
|
|
CVCL_1148 |
2026-09-12 05:24:33 |
1 |
CRO-AP2
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1147
|
Homo sapiens (Human)
|
Primary effusion lymphoma
|
Population: Caucasian., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9389573 PMID:9766492 PMID:10784388 PMID:20164919 PMID:20215515 PMID:20454443 PMID:21685375 PMID:27397505 PMID:30894373 PMID:31160637 PMID:35839778
|
Cancer cell line
|
Male |
CRO-AP/2, CROAP2, AP2 |
|
|
BTO:BTO_0002724, CLO:CLO_0002617, EFO:EFO_0002145, CLDB:cl3486, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioSample:SAMN03473560, cancercelllines:CVCL_1147, Cell_Model_Passport:SIDM00952, ChEMBL-Cells:CHEMBL3308254, ChEMBL-Targets:CHEMBL2366080, Cosmic:906807, Cosmic-CLP:906807, DepMap:ACH-002220, DSMZ:ACC-48, DSMZCellDive:ACC-48, EGA:EGAS00001000978, GDSC:906807, GEO:GSM634729, GEO:GSM1669709, IARC_TP53:21257, IGRhCellID:CROAP2, PharmacoDB:CROAP2_264_2019, PRIDE:PXD030304, Progenetix:CVCL_1147, PubChem_Cell_line:CVCL_1147, Wikidata:Q54814506 |
|
|
CVCL_1147 |
2026-09-12 05:24:33 |
1 |
Daudi
Resource Report
Resource Website
50+ mentions
Discontinued
|
RRID:CVCL_0008
|
Homo sapiens (Human)
|
EBV-related Burkitt lymphoma
|
Caution: TP53 mutation indicated incorrectly as being at c.637C>T in PubMed=2052620., Population: African; Kenyan., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: Human variation panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
|
PMID:170370 PMID:216485 PMID:1325212 PMID:2052620 PMID:2140233 PMID:2470097 PMID:2985879 PMID:2998993 PMID:3026973 PMID:3034807 PMID:3080238 PMID:3100061 PMID:3116544 PMID:3159941 PMID:3518877 PMID:3785169 PMID:3874327 PMID:3905596 PMID:4122458 PMID:4174339 PMID:4178827 PMID:4321974 PMID:4364259 PMID:4878906 PMID:5021706 PMID:6186604 PMID:6200433 PMID:6231253 PMID:6286763 PMID:6500159 PMID:6547209 PMID:6582512 PMID:6592381 PMID:6806672 PMID:6935474 PMID:6954533 PMID:7316467 PMID:7849311 PMID:8176200 PMID:8197130 PMID:8301159 PMID:8515068 PMID:8558913 PMID:8558920 PMID:8568269 PMID:8847894 PMID:9192833 PMID:9473234 PMID:9510473 PMID:9685479 PMID:9737686 PMID:9738977 PMID:9973220 PMID:10739008 PMID:11021758 PMID:11226526 PMID:11894933 PMID:12145705 PMID:12967475 PMID:14504097 PMID:15028022 PMID:16957166 PMID:19358282 PMID:20164919 PMID:20215515 PMID:20454443 PMID:22460905 PMID:22885699 PMID:24590883 PMID:25355872 PMID:25485619 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29892436 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31160637 PMID:35839778
|
Cancer cell line
|
Male |
DAUDI, NK-10A, NK-10a, NK 10a, NK10a, N, GM03190, GM3190, GM03190A, GM17346 |
|
|
BTO:BTO_0001561, CLO:CLO_0002708, CLO:CLO_0013411, CLO:CLO_0013740, CLO:CLO_0050991, EFO:EFO_0002169, MCCL:MCC:0000141, CLDB:cl993, CLDB:cl994, CLDB:cl995, CLDB:cl996, CLDB:cl997, CLDB:cl998, CLDB:cl999, CLDB:cl5181, AddexBio:C0003010/4669, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, ATCC:CCL-213, ATCC:CRL-7917, BCRC:60192, BioGRID_ORCS_Cell_line:1081, BioSample:SAMN00808283, BioSample:SAMN01821546, BioSample:SAMN01821623, BioSample:SAMN03472413, BioSample:SAMN10987948, cancercelllines:CVCL_0008, CCRID:1101HUM-PUMC000134, CCRID:1102HUM-NIFDC00053, CCRID:3101HUMTCHu140, CCRID:4201HUM-CCTCC00097, CCTCC:GDC0097, Cell_Model_Passport:SIDM00845, CGH-DB:9195-4, ChEMBL-Cells:CHEMBL3307579, ChEMBL-Targets:CHEMBL614281, CLS:302009, Coriell:GM03190, Coriell:GM17346, Cosmic:687838, Cosmic:906831, Cosmic:919135, Cosmic:929815, Cosmic:931102, Cosmic:932762, Cosmic:991548, Cosmic:996304, Cosmic:998716, Cosmic:1019315, Cosmic:1037701, Cosmic:1070708, Cosmic:1071878, Cosmic:1086326, Cosmic:1093789, Cosmic:1118470, Cosmic:1176616, Cosmic:1191690, Cosmic:1517663, Cosmic:1995384, Cosmic:2649240, Cosmic:2759407, Cosmic:2760061, Cosmic:2814537, Cosmic:2815216, Cosmic:2823073, Cosmic-CLP:906831, dbMHC:48767, DepMap:ACH-000786, DSMZ:ACC-78, DSMZCellDive:ACC-78, ECACC:85011437, ECACC:94071449, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:EGAS00001002554, FANTOM5_SSTAR:10422-106C8, GDSC:906831, GEO:GSM99381, GEO:GSM862859, GEO:GSM862860, GEO:GSM862861, GEO:GSM862862, GEO:GSM886973, GEO:GSM888042, GEO:GSM960117, GEO:GSM960118, GEO:GSM960119, GEO:GSM960120, GEO:GSM1374459, GEO:GSM1669726, GEO:GSM3150242, GEO:GSM7701371, GEO:GSM7701372, IARC_TP53:143, IARC_TP53:21144, ICLC:HTL95024, IGRhCellID:Daudi, IHW:IHW09366, IPD-IMGT/HLA:10471, IZSLER:BS TCL 104, JCRB:JCRB9071, KCB:KCB 2012116YJ, KCLB:10213, LiGeA:CCLE_233, LINCS_LDP:LCL-2018, Lonza:490, NCBI_Iran:C112, PharmacoDB:Daudi_283_2019, PRIDE:PXD004181, PRIDE:PXD012087, PRIDE:PXD030304, Progenetix:CVCL_0008, PubChem_Cell_line:CVCL_0008, RCB:RCB1640, TKG:TKG 0362, Wikidata:Q54828579 |
|
|
CVCL_0008 |
2026-09-12 05:29:08 |
54 |
Detroit 562
Resource Report
Resource Website
10+ mentions
Discontinued
|
RRID:CVCL_1171
|
Homo sapiens (Human)
|
Pharyngeal squamous cell carcinoma
|
Population: Caucasian., Part of: OPC-22 oral and pharyngeal cancer cell line panel., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:77569 PMID:327080 PMID:833871 PMID:3518877 PMID:5668122 PMID:6220172 PMID:6401685 PMID:6500159 PMID:6988327 PMID:10760816 PMID:12124801 PMID:15197768 PMID:18973137 PMID:20215515 PMID:21868764 PMID:22460905 PMID:24201445 PMID:25275298 PMID:25485619 PMID:25877200 PMID:26589293 PMID:26754630 PMID:27397505 PMID:29156801 PMID:29423072 PMID:30877674 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
DETROIT 562, Detroit-562, Detroit562, DETROIT562, Det 562, Det. 562, Det562, D562 |
|
|
BTO:BTO_0000834, CLO:CLO_0002752, EFO:EFO_0002170, CLDB:cl1035, CLDB:cl1036, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CCL-138, ATCC:CRL-7919, BCRC:60119, BCRJ:0076, BioGRID_ORCS_Cell_line:686, BioSample:SAMN03473286, BioSample:SAMN10988307, cancercelllines:CVCL_1171, CCRID:3101HUMTCHu231, Cell_Model_Passport:SIDM00831, ChEMBL-Cells:CHEMBL3308486, ChEMBL-Targets:CHEMBL1075432, CLS:300399, Cosmic:686974, Cosmic:906837, Cosmic:921830, Cosmic:1006472, Cosmic:1017788, Cosmic:1041673, Cosmic:1339917, Cosmic:1752763, Cosmic:2043891, Cosmic:2296294, Cosmic-CLP:906837, DepMap:ACH-000207, ECACC:87042205, EGA:EGAS00001000610, EGA:EGAS00001000978, FANTOM5_SSTAR:10723-110A3, GDSC:906837, GEO:GSM301580, GEO:GSM827340, GEO:GSM886977, GEO:GSM888046, GEO:GSM1374461, GEO:GSM1374462, GEO:GSM1643590, GEO:GSM1669730, IARC_TP53:2327, IGRhCellID:Detroit562, IZSLER:BS TCL 16, LiGeA:CCLE_046, LINCS_LDP:LCL-1226, PharmacoDB:Detroit562_288_2019, PRIDE:PXD002486, PRIDE:PXD030304, Progenetix:CVCL_1171, PubChem_Cell_line:CVCL_1171, Wikidata:Q54831001 |
|
|
CVCL_1171 |
2026-09-12 05:30:09 |
38 |
DG-75
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_0244
|
Homo sapiens (Human)
|
Burkitt lymphoma
|
Virology: Infected by DG-75 retrovirus, a replication-competent, murine leukemia-related retrovirus. Constitutively produces the virus., Virology: EBV-negative., Population: Jewish; Ashkenazi., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:188769 PMID:2985879 PMID:3037521 PMID:3159941 PMID:3874327 PMID:6169305 PMID:8558920 PMID:8896424 PMID:9473234 PMID:9525742 PMID:9583678 PMID:9685479 PMID:9770427 PMID:11425244 PMID:12706092 PMID:17254797 PMID:20164919 PMID:20215515 PMID:24590883 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
D.G.-75, DG 75, DG75 |
|
|
BTO:BTO_0003637, CLO:CLO_0002767, EFO:EFO_0002160, MCCL:MCC:0000134, CLDB:cl1051, ABM:T8013, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ATCC:CRL-2625, BioSample:SAMN03471755, BioSample:SAMN03473403, cancercelllines:CVCL_0244, Cell_Model_Passport:SIDM00948, CGH-DB:9196-4, ChEMBL-Cells:CHEMBL3308527, ChEMBL-Targets:CHEMBL2366199, Cosmic:906838, Cosmic:931103, Cosmic:1086327, Cosmic:1118471, Cosmic:1191698, Cosmic:1588563, Cosmic-CLP:906838, DepMap:ACH-002232, DSMZ:ACC-83, DSMZCellDive:ACC-83, EGA:EGAS00001000978, GDSC:906838, GEO:GSM710428, GEO:GSM710444, GEO:GSM827239, GEO:GSM1669731, IARC_TP53:8094, IGRhCellID:DG75, LINCS_LDP:LCL-2019, NCBI_Iran:C495, PharmacoDB:DG75_290_2019, PRIDE:PXD004181, PRIDE:PXD030304, Progenetix:CVCL_0244, PubChem_Cell_line:CVCL_0244, TOKU-E:3578, Wikidata:Q54831039 |
|
|
CVCL_0244 |
2026-09-12 05:30:10 |
5 |
DK-MG
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1173
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:20164919 PMID:20215515 PMID:22460905 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
DKMG |
|
|
CLO:CLO_0002782, EFO:EFO_0002161, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:857, BioSample:SAMN03470927, BioSample:SAMN10988036, cancercelllines:CVCL_1173, Cell_Model_Passport:SIDM00947, ChEMBL-Cells:CHEMBL3308814, ChEMBL-Targets:CHEMBL1075433, Cosmic:687566, Cosmic:906839, Cosmic:2302329, Cosmic:2367524, Cosmic:2516016, Cosmic-CLP:906839, DepMap:ACH-000244, DSMZ:ACC-277, DSMZCellDive:ACC-277, EGA:EGAS00001000978, GDSC:906839, GEO:GSM326231, GEO:GSM886978, GEO:GSM888047, GEO:GSM1669734, IARC_TP53:21303, IGRhCellID:DKMG, LiGeA:CCLE_375, LINCS_LDP:LCL-1350, PharmacoDB:DKMG_293_2019, PRIDE:PXD030304, Progenetix:CVCL_1173, PubChem_Cell_line:CVCL_1173, Wikidata:Q54831108 |
|
|
CVCL_1173 |
2026-09-12 05:30:12 |
3 |
Farage
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_3302
|
Homo sapiens (Human)
|
Diffuse large B-cell lymphoma germinal center B-cell type
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9172815 PMID:11378582 PMID:19278952 PMID:19358282 PMID:20215515 PMID:20628145 PMID:23292937 PMID:25485619 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
FARAGE, Farage OL, Farage Original Line |
|
|
CLO:CLO_0002997, EFO:EFO_0006393, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CRL-2630, BioSample:SAMN03471757, cancercelllines:CVCL_3302, CCRID:4201HUM-CCTCC00319, CCTCC:GDC0319, Cell_Model_Passport:SIDM00859, ChEMBL-Cells:CHEMBL4483171, ChEMBL-Targets:CHEMBL4483236, CLS:305071, Cosmic:1295510, Cosmic:1517602, Cosmic:1541919, Cosmic:1945180, Cosmic:2022591, Cosmic:2276315, Cosmic-CLP:1297449, DepMap:ACH-001498, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1297449, GEO:GSM380125, GEO:GSM552429, GEO:GSM907525, GEO:GSM1035331, GEO:GSM1374481, GEO:GSM1669792, IGRhCellID:Farage, LINCS_LDP:LCL-1131, PharmacoDB:Farage_366_2019, PRIDE:PXD028647, PRIDE:PXD030304, Progenetix:CVCL_3302, PubChem_Cell_line:CVCL_3302, Wikidata:Q54833249 |
|
|
CVCL_3302 |
2026-09-12 05:30:57 |
9 |
Farage
Resource Report
Resource Website
1+ mentions
|
ATCC Cat# CRL-2630, RRID:CVCL_3302
|
Homo sapiens (Human)
|
Diffuse large B-cell lymphoma germinal center B-cell type
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9172815 PMID:11378582 PMID:19278952 PMID:19358282 PMID:20215515 PMID:20628145 PMID:23292937 PMID:25485619 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
FARAGE, Farage OL, Farage Original Line |
ATCC |
CRL-2630 |
CLO:CLO_0002997, EFO:EFO_0006393, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CRL-2630, BioSample:SAMN03471757, cancercelllines:CVCL_3302, CCRID:4201HUM-CCTCC00319, CCTCC:GDC0319, Cell_Model_Passport:SIDM00859, ChEMBL-Cells:CHEMBL4483171, ChEMBL-Targets:CHEMBL4483236, CLS:305071, Cosmic:1295510, Cosmic:1517602, Cosmic:1541919, Cosmic:1945180, Cosmic:2022591, Cosmic:2276315, Cosmic-CLP:1297449, DepMap:ACH-001498, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1297449, GEO:GSM380125, GEO:GSM552429, GEO:GSM907525, GEO:GSM1035331, GEO:GSM1374481, GEO:GSM1669792, IGRhCellID:Farage, LINCS_LDP:LCL-1131, PharmacoDB:Farage_366_2019, PRIDE:PXD028647, PRIDE:PXD030304, Progenetix:CVCL_3302, PubChem_Cell_line:CVCL_3302, Wikidata:Q54833249 |
|
|
CVCL_3302 |
2026-09-12 05:30:57 |
9 |
Farage
Resource Report
Resource Website
1+ mentions
|
CCTCC Cat# GDC0319, RRID:CVCL_3302
|
Homo sapiens (Human)
|
Diffuse large B-cell lymphoma germinal center B-cell type
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9172815 PMID:11378582 PMID:19278952 PMID:19358282 PMID:20215515 PMID:20628145 PMID:23292937 PMID:25485619 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
FARAGE, Farage OL, Farage Original Line |
CCTCC |
GDC0319 |
CLO:CLO_0002997, EFO:EFO_0006393, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CRL-2630, BioSample:SAMN03471757, cancercelllines:CVCL_3302, CCRID:4201HUM-CCTCC00319, CCTCC:GDC0319, Cell_Model_Passport:SIDM00859, ChEMBL-Cells:CHEMBL4483171, ChEMBL-Targets:CHEMBL4483236, CLS:305071, Cosmic:1295510, Cosmic:1517602, Cosmic:1541919, Cosmic:1945180, Cosmic:2022591, Cosmic:2276315, Cosmic-CLP:1297449, DepMap:ACH-001498, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1297449, GEO:GSM380125, GEO:GSM552429, GEO:GSM907525, GEO:GSM1035331, GEO:GSM1374481, GEO:GSM1669792, IGRhCellID:Farage, LINCS_LDP:LCL-1131, PharmacoDB:Farage_366_2019, PRIDE:PXD028647, PRIDE:PXD030304, Progenetix:CVCL_3302, PubChem_Cell_line:CVCL_3302, Wikidata:Q54833249 |
|
|
CVCL_3302 |
2026-09-12 05:30:57 |
9 |
GM14439
Resource Report
Resource Website
|
RRID:CVCL_7551
|
Homo sapiens (Human)
|
|
Donor information: Established from monozygotic twin of GM14440 (Cellosaurus=CVCL_7552)., Population: African American., Part of: Human variation panel.
|
PMID:16260726 PMID:20215515 PMID:20398888
|
Transformed cell line
|
Female |
GM17110 |
|
|
CLO:CLO_0014964, CLO:CLO_0031234, Coriell:GM14439, Coriell:GM17110, GEO:GSM273380, GEO:GSM494452, GEO:GSM494453, GEO:GSM569544, GEO:GSM596178, GEO:GSM596978, GEO:GSM827332, GEO:GSM924620, IPD-IMGT/HLA:20689, Wikidata:Q54847210 |
|
|
CVCL_7551 |
2026-09-12 05:35:05 |
0 |
Ej138
Resource Report
Resource Website
Contaminated
|
RRID:CVCL_2443
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Anecdotal: Cell line where the first human oncogene, HRAS was first discovered (PubMed=6286138)., Population: Caucasian; Swedish., Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=3708594; PubMed=6823318; PubMed=20143388)..
|
PMID:651066 PMID:663932 PMID:864752 PMID:870558 PMID:2903891 PMID:3708594 PMID:4027986 PMID:6244232 PMID:6286138 PMID:6823318 PMID:6826254 PMID:7185004 PMID:11416159 PMID:20143388 PMID:20215515 PMID:23401075 PMID:25336970
|
Cancer cell line
|
Female |
EJ138, EJ 138, MGH-U1, MGHU1, MGH-UI, MGH-U1 (EJ), EJ, EJ/T24 |
|
|
BTO:BTO_0003553, CLO:CLO_0002905, CLO:CLO_0002906, EFO:EFO_0022418, CLDB:cl1152, CLDB:cl1154, BioSample:SAMN03151939, BioSample:SAMN03151949, cancercelllines:CVCL_2443, ChEMBL-Cells:CHEMBL3307583, ChEMBL-Targets:CHEMBL614292, Cosmic:760480, Cosmic:925828, Cosmic:1093986, Cosmic:1927289, ECACC:85061108, GEO:GSM827443, GEO:GSM1374473, LINCS_LDP:LCL-1704, NCBI_Iran:C429, Progenetix:CVCL_2443, PubChem_Cell_line:CVCL_2443, Wikidata:Q54832176 |
cvcl_0554 |
|
CVCL_2443 |
2026-09-12 05:30:36 |
0 |
EM-2
Resource Report
Resource Website
|
RRID:CVCL_1196
|
Homo sapiens (Human)
|
Childhood chronic myelogenous leukemia, BCR-ABL1 positive
|
Population: Caucasian., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:3030532 PMID:3332852 PMID:3856862 PMID:10071072 PMID:10576511 PMID:10637496 PMID:20164919 PMID:20215515 PMID:20809971 PMID:22460905 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31160637 PMID:35839778
|
Cancer cell line
|
Female |
EM2 |
|
|
BTO:BTO_0005904, CLO:CLO_0002922, EFO:EFO_0002176, CLDB:cl1164, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioSample:SAMN03472895, BioSample:SAMN10988561, cancercelllines:CVCL_1196, Cell_Model_Passport:SIDM01047, ChEMBL-Cells:CHEMBL3308889, ChEMBL-Targets:CHEMBL2366281, Cosmic:787491, Cosmic:906855, Cosmic:994175, Cosmic:1026572, Cosmic:1078728, Cosmic:1498416, Cosmic-CLP:906855, DepMap:ACH-000295, DSMZ:ACC-135, DSMZCellDive:ACC-135, EGA:EGAS00001000978, GDSC:906855, GEO:GSM887004, GEO:GSM888073, GEO:GSM1374474, GEO:GSM1669762, IARC_TP53:340, IARC_TP53:21326, IGRhCellID:EM2, LiGeA:CCLE_641, LINCS_LDP:LCL-1112, PharmacoDB:EM2_331_2019, PRIDE:PXD030304, Progenetix:CVCL_1196, PubChem_Cell_line:CVCL_1196, Wikidata:Q54832264 |
|
|
CVCL_1196 |
2026-09-12 05:30:38 |
0 |
Eos-HL-60
Resource Report
Resource Website
|
RRID:CVCL_2892
|
Homo sapiens (Human)
|
Adult acute myeloid leukemia with maturation
|
Population: Caucasian.
|
PMID:20215515
|
Cancer cell line
|
Female |
|
|
|
CLO:CLO_0002936, CLDB:cl5062, cancercelllines:CVCL_2892, ECACC:96100920, GEO:GSM827454, LINCS_LDP:LCL-2055, Progenetix:CVCL_2892, Wikidata:Q54832346 |
cvcl_0002 |
|
CVCL_2892 |
2026-09-12 05:30:40 |
0 |